. | Wild-type genotype TCF7L2 (n = 21) . | Risk genotype TCF7L2 (n = 18) . | P value . |
---|---|---|---|
Incretin effect (%) | 37.8 (12.5, 52.9) | 0.3 (−7.2, 14) | 0.002 |
Age (years) | 16 (15, 18) | 15 (14, 17) | 0.336 |
Male sex | 12 (57) | 8 (44) | 0.527 |
BMI (kg/m2) | 37.0 (32.7, 41.0) | 40.6 (34.8, 44.8) | 0.499 |
Tanner stage | 0.306 | ||
II–III | 9 (43) | 10 (55) | |
IV–V | 12 (57) | 8 (44) | |
Ethnicity | 0.087 | ||
Non-Hispanic White | 2 (9) | 7 (39) | |
Non-Hispanic Black | 9 (43) | 4 (22) | |
Hispanic | 10 (48) | 7 (39) | |
IFG | 1 (13) | 2 (20) | 0.855 |
IGT | 4 (31) | 6 (46) | 0.350 |
Fasting glucose (mg/dL) | 90 (86.5, 96.5) | 94 (89, 100) | 0.222 |
1-h glucose (mg/dL) | 153 (134, 168) | 163.5 (147, 189) | 0.015 |
2-h glucose (mg/dL) | 134 (127, 146) | 135.5 (119, 173) | 0.526 |
Fasting insulin (μU/mL) | 41 (26.5, 45.5) | 28.8 (20.5, 62.5) | 0.307 |
Fasting C-peptide (pmol/L) | 1,001 (901.5, 1,279) | 1,019 (823.5, 1,121.5) | 0.887 |
Fasting GLP-1(7-36) (pmol/L) | 2.0 (1.06, 16.7) | 2.9 (1.30, 11.2) | 0.868 |
Fasting glucagon (pmol/L) | 6.9 (4.9, 8.1) | 9.45 (6.6, 10.5) | 0.474 |
. | Wild-type genotype TCF7L2 (n = 21) . | Risk genotype TCF7L2 (n = 18) . | P value . |
---|---|---|---|
Incretin effect (%) | 37.8 (12.5, 52.9) | 0.3 (−7.2, 14) | 0.002 |
Age (years) | 16 (15, 18) | 15 (14, 17) | 0.336 |
Male sex | 12 (57) | 8 (44) | 0.527 |
BMI (kg/m2) | 37.0 (32.7, 41.0) | 40.6 (34.8, 44.8) | 0.499 |
Tanner stage | 0.306 | ||
II–III | 9 (43) | 10 (55) | |
IV–V | 12 (57) | 8 (44) | |
Ethnicity | 0.087 | ||
Non-Hispanic White | 2 (9) | 7 (39) | |
Non-Hispanic Black | 9 (43) | 4 (22) | |
Hispanic | 10 (48) | 7 (39) | |
IFG | 1 (13) | 2 (20) | 0.855 |
IGT | 4 (31) | 6 (46) | 0.350 |
Fasting glucose (mg/dL) | 90 (86.5, 96.5) | 94 (89, 100) | 0.222 |
1-h glucose (mg/dL) | 153 (134, 168) | 163.5 (147, 189) | 0.015 |
2-h glucose (mg/dL) | 134 (127, 146) | 135.5 (119, 173) | 0.526 |
Fasting insulin (μU/mL) | 41 (26.5, 45.5) | 28.8 (20.5, 62.5) | 0.307 |
Fasting C-peptide (pmol/L) | 1,001 (901.5, 1,279) | 1,019 (823.5, 1,121.5) | 0.887 |
Fasting GLP-1(7-36) (pmol/L) | 2.0 (1.06, 16.7) | 2.9 (1.30, 11.2) | 0.868 |
Fasting glucagon (pmol/L) | 6.9 (4.9, 8.1) | 9.45 (6.6, 10.5) | 0.474 |
Data are median (25th, 75th percentile) or n (%). Boldface indicates significance at P < 0.05.